Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice.
about
The role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitisHyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat dietEffect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trialPhospholipase A(2) enzymes in metabolic and cardiovascular diseases.Lysophosphatidic acid in atherosclerotic diseasesModulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A(2)Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes.Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetesPlatelet activating factor in heart failure: potential role in disease progression and novel target for therapy.Darapladib for the treatment of cardiovascular disease.Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice.Unraveling the PAF-AH/Lp-PLA2 controversy.Atherosclerosis Is an Inflammatory Disease which Lacks a Common Anti-inflammatory Therapy: How Human Genetics Can Help to This Issue. A Narrative Review.
P2860
Q27310393-9D4BDD0C-F861-4AA3-BECF-6DF35AA5667AQ28482520-4BB24C5B-AD7E-4B11-825C-6078289FC010Q28539991-D49B7D6D-7CA8-4C3D-8284-5D369DC78174Q33773427-D34878CC-00B1-4078-80D5-7F457F3914C7Q34273486-7C778C7C-8F19-4575-8EAB-27C1A63EAA6EQ36145180-261BE5C7-AC33-4ECB-8435-97CF7D6DC068Q36547608-48A2899D-DBD0-4C3C-B4D2-FD83FD4E2FA9Q37065040-95770664-957A-4296-AC4D-2C00859B2B2EQ37431606-1F12C094-FFDD-4A27-AA9E-475118E3C29DQ38079764-DA9AEDAF-7BDE-414B-8557-0A02158B384CQ38293061-99801D9A-A8AE-46C5-B4B4-181B81E80D53Q38836998-0FDFCAA8-00A6-45DA-B1F0-134AF8EF801AQ42755958-F034635D-B8ED-4909-BEFE-E9553E92537BQ43204699-CA95A2DC-1B8E-45AA-ABE4-D23DDA9C1378Q50318400-9BE50651-F61D-4827-926D-552E2E575200
P2860
Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@ast
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@en
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@nl
type
label
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@ast
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@en
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@nl
prefLabel
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@ast
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@en
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@nl
P2093
P2860
P1433
P1476
Inhibition of lipoprotein-asso ...... mation in ApoE-deficient mice.
@en
P2093
Jian-hua Shen
Wei-hai Chen
Wen-wei Xu
Wen-yi Wang
Yan-ling Ma
P2860
P304
P356
10.1371/JOURNAL.PONE.0023425
P407
P577
2011-08-31T00:00:00Z